Clinical trial
Excimer Laser Combined With DCB Compared With Angioplasty Alone in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb Ischemia.
NCT04365075 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Excimer Laser Combined With DCB Compared With Angioplasty Alone in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb Ischemia.
- Lead sponsor
- Xuanwu Hospital, Beijing
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 1, 2019
- Completion date
- December 31, 2022
- Enrollment
- 184 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
critical limb ischemia, infrapopliteal lesions